Diverse capabilities in MR reflect the corporate philosophies of individual vendors, as well as how they see opportunities in the marketplace and seek to capitalize on them
Diverse capabilities in MR reflect the corporate philosophies of individual vendors, as well as how they see opportunities in the marketplace and seek to capitalize on them. Some vendors have put their own special twist on patient comfort. Others have developed novel technologies in their traditional pursuit of improved image quality with nontraditional technologies. In this section, MR vendors describe the processes that have shaped their products and how those products reflect their assessments of customer needs.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.